Skip to main content

Month: September 2020

Berkeley Lights Makes Debut in Taiwan as Mycenax Acquires the BeaconⓇ Optofluidic System for Cell Line Development

MIAOLI, Taiwan and EMERYVILLE, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) — Mycenax Biotech, Inc. (4726.TWO), a pioneer of biopharmaceutical development in Taiwan, today announced its adoption of the Berkeley Lights Platform for cell line development. Berkeley Lights, Inc., (Nasdaq: BLI), a leader in Digital Cell Biology, continues to see adoption of the system in Asia Pacific, as Mycenax becomes the first company in Taiwan to use the technology.“At Mycenax, we strive to be a leader in comprehensive biologics development with the highest standards of technology and manufacturing,” said Pei-Jiun Chen, Ph.D., CEO of Mycenax. “We are excited to work with the Berkley Lights team to enhance our existing services, and we believe the BeaconⓇ system enables a big jump to the next level of success in cell line development.”Mycenax develops...

Continue reading

Update: DRAFT RESOLUTIONS of the Annual General Meeting of Shareholders of JSC „Olainfarm” to be held on September 22, 2020

Draft resolutions of the Annual General Meeting of Shareholders of JSC „Olainfarm” to be held on September 22, 2020 at 10:00 are supplemented with Remuneration Policy.Additional information:       Jānis DubrovskisInvestor Relations Advisor of JSC OlainfarmPh.: +371 29178878janis.dubrovskis@olainfarm.comAttachmentRemuneration Policy ENG

Continue reading

Papildināts: Akciju sabiedrības “Olainfarm”, reģistrācijas numurs 40003007246, kārtējās 2020.gada 22.septembra akcionāru sapulces LĒMUMU PROJEKTI

Akciju sabiedrības “Olainfarm”, reģistrācijas numurs 40003007246, kārtējās 2020.gada 22.septembra plkst. 10.00 akcionāru sapulces lēmumu projekti ir papildināti ar Atalgojuma politiku.Papildu informācija:Jānis DubrovskisAkciju sabiedrības “Olainfarm” investoru attiecību konsultantsTel. +371 29178878E-pasts: janis.dubrovskis@olainfarm.comPielikumsAtalgojuma politika_LAT

Continue reading

Lamar Advertising to appear at the Goldman Sachs 29th Annual Communacopia Conference

BATON ROUGE, La., Sept. 09, 2020 (GLOBE NEWSWIRE) — Lamar Advertising Company (Nasdaq: LAMR) today announced that Sean Reilly, CEO of Lamar Advertising Company, is scheduled to participate in a question-and-answer session at the Goldman Sachs 29th Annual Communacopia Conference on Wednesday, September 16, 2020, at approximately 4:35 p.m. (ET).The question and answer session will be carried live via audio webcast at the Company’s website, www.lamar.com, and will be archived for 30 days.About Lamar Advertising CompanyFounded in 1902, Lamar Advertising Company is one of the largest outdoor advertising companies in North America, with more than 385,000 displays across the United States and Canada. Lamar offers advertisers a variety of billboard, interstate logo, transit and airport advertising formats, helping both local businesses...

Continue reading

Nicolas Namias is appointed Chairman of the Board of COFACE SA

Paris, 9 September 2020 – 17:45Nicolas Namias is appointed Chairman of the Board of COFACE SAThe Board of Directors of COFACE SA met today and elected as its new Chairman Nicolas Namias, Chief Executive Officer of Natixis.He succeeds François Riahi, who is leaving the COFACE SA board following his departure from Natixis.The Board would like to thank François Riahi for his contribution as Chairman of the Board of Directors of COFACE SA. His chairmanship notably saw the launch of the Build to Lead strategic plan.“I am very honoured by the confidence placed in me by the Board of Directors. Together with Xavier Durand and the teams across Coface, we will continue to pursue the implementation of Build to Lead with determination. The plan’s relevance and strategic axes are as critical as ever in the current environment, which is affected...

Continue reading

Nicolas Namias est nommé président du conseil d’administration de COFACE SA

Paris, 9 septembre – 17h45Nicolas Namias est nommé président du conseil d’administration de COFACE SALe conseil d’administration de COFACE SA s’est réuni ce jour et a nommé Nicolas Namias, directeur général de Natixis, en qualité de président du conseil d’administration.Il succède à François Riahi qui quitte le conseil d’administration de COFACE SA à la suite de son départ de Natixis.Le conseil tient à remercier François Riahi pour sa contribution en tant que président du conseil d’administration de COFACE SA. Sa présidence a été marquée notamment par le lancement du nouveau plan Build to Lead.« Je suis très honoré de la confiance que me témoigne aujourd’hui le conseil d’administration. Avec Xavier Durand et les équipes de Coface, nous allons poursuivre avec détermination la mise en œuvre du plan Build to Lead dont la pertinence et les...

Continue reading

Inventiva to participate at several investor conferences in September 2020

Daix (France), September 9, 2020 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today announced that its management team will participate to five investor conferences in September 2020.The event details are as follows:Conference n°1: H.C. Wainwright 22nd Annual Global Investment Virtual ConferenceEvent type: Corporate presentation, one-on-one investor meetingsDate: Wednesday, September 16, 2020Time: 11:00 am – 11:20 am (Eastern Time) / 5:00 pm – 5:20 pm (Paris Time)Format: Virtual presentationLive link: https://wsw.com/webcast/hcw7/iva/1469344Conference n°2: Roth Analyst Management Talk SeriesEvent...

Continue reading

Inventiva participera à plusieurs conférences investisseurs en septembre 2020

Daix (France), 9 septembre 2020 – Inventiva (Euronext Paris et Nasdaq : IVA), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par voie orale pour le traitement de la stéatohépatite non alcoolique (NASH), des mucopolysaccharidoses (MPS) et d’autres maladies avec un besoin médical non satisfait significatif, annonce aujourd’hui que son équipe de direction participera à cinq conférences investisseurs au cours du mois de septembre 2020.Les détails des évènements sont les suivants :Conférence n°1: « H.C. Wainwright 22nd Annual Global Investment Virtual Conference »Type d’évènement : Présentation de la Société, rendez-vous investisseursDate : Mercredi 16 septembre 2020Heure : 11h00 – 11h20 (heure de la côte Est) / 17h00 – 17h20 (heure de Paris)Format : Présentation virtuelleLien : https://wsw.com/webcast/hcw7/iva/1469344Conférence...

Continue reading

LINEDATA: Half year results 2020: Net margin rate stable at 9.7%

            Half year results 2020:Net margin rate stable at 9.7%          Rounded, audited figures (€M)Neuilly-sur-Seine, September 9, 2020 – Linedata (LIN:FP), a global solutions and outsourcing services provider for asset management, insurance, and credit professionals, showed a moderate decline in its profitability indicators for the first half of 2020 in a global economic environment impacted by the Covid-19 health crisis.The Group achieved half-year revenues of €78.5 million, down 7.4% compared to the first half of 2019. This erosion of revenue is more pronounced in client segments that rely more heavily on consulting and customization resources, due in particular to difficulties for employees to access client sites. Conversely, SaaS (Software-as-a-Service), recurring license rental fees and maintenance are trending well with an...

Continue reading

LINEDATA: Résultats semestriels 2020 : Taux de Marge nette stable à 9,7%

            Résultats semestriels 2020 :Taux de Marge nette stable à 9,7%          Chiffres arrondis et audités (M€)Neuilly-sur-Seine, le 9 septembre 2020 – Linedata (LIN:FP), éditeur de solutions globales et prestataire de services d’outsourcing pour les professionnels de l’asset management, de l’assurance et du crédit affiche pour le 1er semestre 2020 une diminution modérée de ses indicateurs de rentabilité dans une conjoncture économique mondiale impactée par la crise sanitaire du Covid-19.Le Groupe a réalisé un chiffre d’affaires semestriel de 78,5 M€, en baisse de 7,4% par rapport au 1er semestre 2019. L’érosion du revenu est plus sensible dans les segments de marché faisant plus largement appel aux ressources de consulting et de customisation, en raison notamment des difficultés d’accès aux sites clients pour les collaborateurs....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.